Taxotere Lawsuit Moves Forward

To expedite claims, the federal Judicial Panel on Multidistrict Litigation has transferred all pending Taxotere cases to the U.S. District Court for the Eastern District of Louisiana.

Sanofi-Aventis obtained the Food ad Drug Administration’s permission to sell Taxotere in 1996. Over the years, hundreds of victims filed suit, alleging that the manufacturer failed to adequately warn them about potential serious side effects. The plaintiffs also allege that, contrary to the manufacturer’s claims, this drug is only marginally more effective than some of its safer counterparts and Sanofi-Aventis used kickbacks and other illegal measures to promote and sell Taxotere.

07 November

0 Comments

Sticky

Judge Awards $2.5 Million to Gynecomastia victim that took Risperdal

Posted by Gary Logsdon Law

in Defective Drugs

A Philadelphia court jury awarded $2.5 Million to the family of an autistic boy who developed male breasts after taking the drug Risperdal beginning in 2002. This is a big setback for the large drug manufacturer Johnson & Johnson who was reported to failed to warn people that taking Risperdal, an antipsychotic drug, might cause gynecomastia better known as male breast development. You can find out more information about Gynecomastia and the Side Effects of Risperdal. This case is the first lawsuit that proves J&J hid the possible side affects of the drug including gynecomastia. Johnson and Johnson settled many cases years ago involving...